Page last updated: 2024-08-17

galactose and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

galactose has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed, W; Crean, S; Elhissi, A; Faheem, A; Hidayat, K; Mwesigwa, E; Phoenix, DA; Taylor, KM1

Other Studies

1 other study(ies) available for galactose and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ArticleYear
Air-jet and vibrating-mesh nebulization of niosomes generated using a particulate-based proniosome technology.
    International journal of pharmaceutics, 2013, Feb-28, Volume: 444, Issue:1-2

    Topics: Aerosols; Air; Beclomethasone; Bronchodilator Agents; Cholesterol; Hexoses; Liposomes; Microscopy, Electron, Transmission; Nebulizers and Vaporizers; Particle Size; Respiratory System; Sucrose; Vibration

2013